Tay MZ., Tang W., Lee W-C., Ong ASM., Novera W., Malleret B., Carissimo G., Chacko A-M., El-Sahili A., Lescar J., Fan Y., McGready RM., Chu CS., Chan JKY., Ng LFP., Russell B., Nosten F., Rénia L.

Abstract We previously described a novel Plasmodium vivax invasion mechanism into human reticulocytes via the PvRBP2a-CD98 receptor-ligand pair. Using linear epitope mapping, we assessed the PvRBP2a epitopes involved in CD98 binding and recognized by antibodies from patients who were infected. We identified 2 epitope clusters mediating PvRBP2a-CD98 interaction. Cluster B (PvRBP2a431-448, TAALKEKGKLLANLYNKL) was the target of antibody responses in humans infected by P vivax. Peptides from each cluster were able to prevent live parasite invasion of human reticulocytes. These results provide new insights for development of a malaria blood-stage vaccine against P vivax.

Functional and Immunologic Mapping of Domains of the Reticulocyte-Binding Protein Plasmodium vivax PvRBP2a

Tay MZ., Tang W., Lee W-C., Ong ASM., Novera W., Malleret B., Carissimo G., Chacko A-M., El-Sahili A., Lescar J., Fan Y., McGready RM., Chu CS., Chan JKY., Ng LFP., Russell B., Nosten F., Rénia L.

DOI

Type

Publisher

Publication Date

Volume

Pages